Invivoscribe Controls Portfolio Catalogue 2024
Discover the Invivoscribe control portfolio
Invivoscribe offers an extensive range of General Purpose Reagents (GPRs) and Research Use Only (RUO) controls.
11Oct
News
28May
Invivoscribe NPM1 MRD Assay
Just launched! NPM1 MRD Assay* by Invivoscribe.
21Mar
New Invivoscribe FLT3 ITD MRD Assay
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
Just launched! Invivoscribe’s FLT3 ITD MRD Assay for Acute Myeloid Leukemia (AML)
21Mar
Advantages of Using LymphoTrack Assays
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
Invivoscribe LymphoTrack® products can be used for next-generation sequencing (NGS) determination and minimal residual disease (MRD) tracking of B- and T-cell gene rearrangements in subjects suspected of lymphoproliferations.
05Jul
Advantages of NGS for MRD testing
Products are for professional/laboratory use only
Explore Recent Scientific Contributions Using Invivoscribe’s Products
Key opinion leaders across the world have recently published papers that discuss the advantages of using highly sensitive next-generation sequencing (NGS) for Minimal Residual Disease (MRD) testing.
22Jan
Invivoscribe’s NGS Assay for determining Somatic Hypermutation status in patients with chronic lymphocytic leukemia (CLL).
Products are for professional/laboratory use only.
The immunoglobulin heavy-chain variable region gene (IgHV) mutational status is considered the gold standard for prognosis in chronic lymphocytic leukemia (CLL)1.
03Feb
Invivoscribe’s EHA Symposiums Now Available on Demand
Products are for professional/laboratory use only.
The Invivoscribe symposiums presented during the 25th European Hematology Association Virtual Congress are now available to watch on demand.
02Feb
Utility of NGS Assays for the Evaluation of Lymphoid Malignancies – Webinar
Products are for professional/laboratory use only.
This webinar will explore how insights gained through NGS translate to the development of improved treatment of lymphoid malignancies.
02Feb
Invivoscribe MRD controls NOW AVAILABLE
Products are for professional/laboratory use only.
Abacus dx is pleased to announce the launch of the new LymphoTrack B-cell Low Positive Controls and LymphoQuant B-cell Internal Controls as part of Invivoscribe’s MRD B-Cell Bundled Solution.